| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/17/2001 | EP1068318A2 Human nucleic acid sequences from prostate tissue |
| 01/17/2001 | EP1068317A2 Human nucleic acid sequences from prostate tumour tissue |
| 01/17/2001 | EP1068316A1 Blk genes, gene products and uses thereof in apoptosis |
| 01/17/2001 | EP1068315A2 Therapeutic agent for ngf |
| 01/17/2001 | EP1068314A1 Highly active forms of interferon regulatory factor proteins |
| 01/17/2001 | EP1068313A2 Collagen peptides and uses thereof |
| 01/17/2001 | EP1068312A2 5' ests and encoded human proteins |
| 01/17/2001 | EP1068311A1 Methods and means for obtaining modified phenotypes |
| 01/17/2001 | EP1068310A1 Method for screening compounds capable of inhibiting fixing between the transcription factor of stat1 and the transcription factor of usf1 |
| 01/17/2001 | EP1068309A2 Enterotoxin-deficient bacillus |
| 01/17/2001 | EP1068308A1 Secreted proteins and polynucleotides encoding them |
| 01/17/2001 | EP1068307A1 Secreted proteins and polynucleotides encoding them |
| 01/17/2001 | EP1068306A1 Pentaerythritol lipid derivatives |
| 01/17/2001 | EP1068305A2 High throughput dna sequencing vector |
| 01/17/2001 | EP1068301A2 Bacterial transglutaminases |
| 01/17/2001 | EP1068296A1 Methods and compositions for eliciting an immune response to a telomerase antigen |
| 01/17/2001 | EP1068295A1 Cell differentiation/proliferation and maintenance factor and uses thereof |
| 01/17/2001 | EP1068294A1 Microbial strains and processes for the manufacture of biomaterials |
| 01/17/2001 | EP1068241A1 Antibody variants and fragments thereof |
| 01/17/2001 | EP1068238A1 An integrin heterodimer and a subunit thereof |
| 01/17/2001 | EP1068237A1 T cell receptor expression cassette |
| 01/17/2001 | EP1068236A1 Human oxidized ldl receptor |
| 01/17/2001 | EP1068235A1 G-protein coupled receptors |
| 01/17/2001 | EP1068232A2 Human antibiotic proteins |
| 01/17/2001 | EP1068231A2 Human nucleic acid sequences of normal ovary tissue |
| 01/17/2001 | EP1068230A1 Chimeric insecticidal protein and gene coding therefore |
| 01/17/2001 | EP1068229A1 Peptides |
| 01/17/2001 | EP1068228A1 Protease conjugates |
| 01/17/2001 | EP1068226A1 Lipopeptides inducing t lymphocytic cytotoxicity bearing at least one auxiliary t epitope, and uses for vaccination |
| 01/17/2001 | EP1068220A1 nrdF |
| 01/17/2001 | EP1068218A2 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders |
| 01/17/2001 | EP1068217A1 Novel molecules of the card-related protein family and uses thereof |
| 01/17/2001 | EP1068216A2 Libraries of oligomers labelled with different tags |
| 01/17/2001 | EP1068188A1 Novel nucleic acid transfer agents, compositions containing same and uses |
| 01/17/2001 | EP1067969A1 Polyene macrolide derivatives, use for vectoring molecules |
| 01/17/2001 | EP1067968A1 Methods for evaluating a compound for its effect on skin |
| 01/17/2001 | EP1067962A2 Derivatives of pneumococcal choline binding proteins for vaccines |
| 01/17/2001 | EP1067961A2 Leishmania cysteine proteinases |
| 01/17/2001 | EP1067954A1 USE OF ANTI-gp39 ANTIBODIES FOR TREATMENT AND/OR REVERSAL OF LUPUS AND ASSOCIATED KIDNEY DISEASE |
| 01/17/2001 | EP1067952A1 Methods for treatment and prevention of infections |
| 01/17/2001 | EP1067940A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 01/17/2001 | EP1067917A2 Method of treating dopaminergic and gaba-nergic disorders |
| 01/17/2001 | EP1067909A1 Cationic lipid formulation delivering nucleic acid to peritoneal tumors |
| 01/17/2001 | EP1067893A2 Human galactosyl transferases |
| 01/17/2001 | EP1067834A1 Porcine nuclear transfer |
| 01/17/2001 | EP0948408A4 Microfabricated sleeve devices for chemical reactions |
| 01/17/2001 | EP0941318B1 Dumbbell expression constructs for gene therapy |
| 01/17/2001 | EP0792374B1 Self-quenching fluorescence probe and method |
| 01/17/2001 | EP0788555B1 Methods of analysis and manipulation of dna utilizing mismatch repair systems |
| 01/17/2001 | EP0771216B1 Methods and compositions for the specific coagulation of tumoral vasculature |
| 01/17/2001 | EP0680315B1 Method for preparing a viral aerosol |
| 01/17/2001 | EP0672158B1 Adenovirus with genetic fusion of penton fibre to peptide altering binding specificity |
| 01/17/2001 | EP0640135B1 Immunoglobulin binding proteins derived from l protein and their uses |
| 01/17/2001 | CN1280627A Proteinase inhibitor fusion proteins |
| 01/17/2001 | CN1280626A Pre-and posharvest inhibition of remobilisation of storage compounds |
| 01/17/2001 | CN1280625A Nuclear male sterile plants, method of producing same and method to restore fertility |
| 01/17/2001 | CN1280624A Nucleic and molecules which encode proteins having fructosyl transterase activity and methods for producing long-chain inulin |
| 01/17/2001 | CN1280623A Method and compositions useful for activation of silent transgenes |
| 01/17/2001 | CN1280622A Modification of the tocopherol content of transgenic plants |
| 01/17/2001 | CN1280621A Alkaline protease |
| 01/17/2001 | CN1280620A Antigen protein and nucleic acid coding for said protein |
| 01/17/2001 | CN1280619A (Chlamydia trachomatic) genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 01/17/2001 | CN1280618A Protein involved in abscisic acid signalling |
| 01/17/2001 | CN1280617A TSA 305 gene |
| 01/17/2001 | CN1280616A Method and compositions for inducing tumor-specific cytotoxicity |
| 01/17/2001 | CN1280615A Expression of endogenous genes by non-homologons recombination of a vactor construct with cellular DNA |
| 01/17/2001 | CN1280614A Recombinational cloning using nucleic acids having recombinatin sites |
| 01/17/2001 | CN1280613A Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor |
| 01/17/2001 | CN1280586A Erythropoietin with high specific activity |
| 01/17/2001 | CN1280501A Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 01/17/2001 | CN1280457A Nepovirus resistance in grapevine |
| 01/17/2001 | CN1280190A Recombined anti-human TNF alpha gene engineering anti-bogy and its preparing method |
| 01/17/2001 | CN1280188A Continuous producing method of recombined phage in biologicl film reactor |
| 01/17/2001 | CN1280186A New type low temperature akaline protease and its producing method and use and microbe for producing said protease |
| 01/17/2001 | CN1280185A Corynebaclerium for producing L-lysine and method for producing L-lysine |
| 01/17/2001 | CN1280184A Corgnebaclerium for producing L-lysine and method for preparing L-lysine |
| 01/17/2001 | CN1280137A Erythrocyte-stimulating factor coupling |
| 01/17/2001 | CN1280136A Gene sequence and amino-acid sequence of varient omega-conch toxin polypeptide and their preparing method and medicinal use |
| 01/17/2001 | CN1280135A Method for producing L-leucine and related DNA and microorganism |
| 01/17/2001 | CN1280012A Electric pulse transfer technology of IFN gene |
| 01/17/2001 | CN1060811C Autonomic replicating vector for construction of recombinant adenovirus concomitant virus packaging system and use thereof |
| 01/17/2001 | CN1060810C Formation of plasmid-type herpes-virus carrier for specific expression of human nerve cell and use of same |
| 01/17/2001 | CN1060809C Autonomic replicative and liver cancer specific expressive guide gene transfer system and its application |
| 01/17/2001 | CN1060808C Autonomic-replication-type carrier in human's liver-cancer cell specific expression and use thereof |
| 01/17/2001 | CN1060807C Method for producing plasmid of expression external gene and ox prorennin in colonbacillus |
| 01/17/2001 | CN1060806C Gene sequence of fibrin fermant of Agkistrodon acutus snake |
| 01/17/2001 | CN1060805C High demonstration by artificial human gamma-interferon (C DNA) in colonbacillus |
| 01/17/2001 | CN1060804C IV collagen enzyme specific antibody for human gene engineering |
| 01/16/2001 | US6175061 Production of polyhydroxyalkanoate in plants |
| 01/16/2001 | US6175060 Transgenic plant having a cell transformed by a vector including dna which activates transcription of a structural gene under conditions of phosphate-starvation; recombinant production of proteins; disease resistance |
| 01/16/2001 | US6175059 Development of a novel gene delivery system through seed coating |
| 01/16/2001 | US6175058 Nucleotide sequence having maize-preferred codons; for transformed plants allowing efficient site-directed recombination |
| 01/16/2001 | US6175057 Transgenic mouse model of alzheimer's disease and cerebral amyloid angiopathy |
| 01/16/2001 | US6175006 Automated system for polynucleotide synthesis and purification |
| 01/16/2001 | US6175003 Nucleic acids encoding ribonucleases and methods of making them |
| 01/16/2001 | US6175002 Double stranded nucleic acid adaptor having a 3' blocked protuding strand; prevents self-ligation for more efficient and reliable methods |
| 01/16/2001 | US6175001 Derivatized at c5 to contain functional group that mimics the property of naturally occurring amino acid; for use in polymerase chain reactions |
| 01/16/2001 | US6174997 Antibody which specifically binds polypeptide of defined amino acid sequence; diagnosis of non-hodgkin's lymphoma; anticarcinogenic agents |
| 01/16/2001 | US6174996 Fusion protein with reduced side effects; for use as viricides, anticarcinogenic/antitumor/antiproliferative agents in humans and animals; feline leukemia virus; human immunodeficiency virus; hepatitis b and c viruses |
| 01/16/2001 | US6174994 7TM receptor (H2CAA71) |